US Stock MarketDetailed Quotes
AURA Aura Biosciences
- 7.500
- +0.280+3.88%
Close Apr 29 16:00 ET
- 7.500
- 0.0000.00%
Post 16:01 ET
371.50MMarket Cap-3886P/E (TTM)
7.930High7.310Low121.71KVolume7.310Open7.220Pre Close913.40KTurnover0.39%Turnover RatioLossP/E (Static)49.53MShares13.50052wk High1.64P/B232.41MFloat Cap5.99052wk Low--Dividend TTM30.99MShs Float26.160Historical High--Div YieldTTM8.59%Amplitude5.990Historical Low7.504Avg Price1Lot Size
Aura Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -16.93%-63.85M | 3.48%-17.39M | -43.15%-15.4M | -37.80%-14.65M | -7.97%-16.41M | -68.47%-54.6M | -49.04%-18.01M | -23.82%-10.76M | -63.58%-10.63M | -195.89%-15.2M |
| Net income from continuing operations | -30.03%-76.41M | -33.65%-22.13M | -16.42%-18.51M | -35.87%-18.3M | -36.08%-17.47M | -66.70%-58.76M | -42.33%-16.56M | -79.92%-15.9M | -52.15%-13.47M | -116.55%-12.84M |
| Operating gains losses | 1,045.45%208K | -30.07%207K | ---- | ---- | ---- | -833.33%-22K | 4,833.33%296K | ---- | ---- | -25.00%-5K |
| Depreciation and amortization | 10.03%1.3M | 0.31%324K | 13.58%343K | 1.35%300K | 28.13%328K | 41.64%1.18M | 40.43%323K | 39.81%302K | 48.00%296K | 38.38%256K |
| Other non cash items | 89.77%1.84M | 98.06%715K | 42.01%453K | 130.17%557K | 143.48%112K | 6,353.33%968K | 2,908.33%361K | 7,875.00%319K | 7,966.67%242K | 1,250.00%46K |
| Change In working capital | 215.47%4.44M | 150.60%2.03M | -75.34%808K | 64.98%1.89M | 93.06%-295K | -1,120.95%-3.85M | -101.30%-4.02M | 672.90%3.28M | -37.13%1.15M | -1,093.22%-4.25M |
| -Change in prepaid assets | 210.02%3.58M | 114.19%520K | -167.61%-881K | 114.58%1.65M | 238.07%2.29M | 9.01%-3.25M | -21.77%-3.66M | 235.45%1.3M | 101.57%768K | -11,166.67%-1.66M |
| -Change in payables and accrued expense | 295.47%2.27M | 521.77%1.97M | -11.76%1.92M | 13.99%766K | 7.87%-2.39M | -82.39%574K | -68.68%317K | 457.95%2.18M | -53.49%672K | -727.36%-2.59M |
| -Change in other current assets | 79.67%-86K | 141.61%176K | --15K | ---77K | ---200K | ---423K | ---423K | --0 | --0 | --0 |
| -Change in other current liabilities | -77.69%-1.32M | -153.20%-633K | -21.78%-246K | ---- | ---- | ---744K | ---250K | ---202K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -16.93%-63.85M | 3.48%-17.39M | -43.15%-15.4M | -37.80%-14.65M | -7.97%-16.41M | -68.47%-54.6M | -49.04%-18.01M | -23.82%-10.76M | -63.58%-10.63M | -195.89%-15.2M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -67.92%-113.96M | -434.01%-90.12M | 20.52%21.63M | 149.28%21.41M | -162.29%-66.88M | -3,093.84%-67.87M | -1,960.56%-16.88M | 3,231.94%17.95M | -6,462.08%-43.44M | -35,812.68%-25.5M |
| Net PPE purchase and sale | 35.19%-709K | 11.45%-317K | -42.86%-90K | -160.81%-193K | 81.80%-109K | 48.52%-1.09M | 56.29%-358K | 89.01%-63K | 88.82%-74K | -743.66%-599K |
| Net investment purchase and sale | -69.61%-113.25M | -443.67%-89.8M | 20.60%21.72M | 149.81%21.6M | -168.16%-66.77M | ---66.78M | ---16.52M | --18.01M | ---43.37M | ---24.9M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -67.92%-113.96M | -434.01%-90.12M | 20.52%21.63M | 149.28%21.41M | -162.29%-66.88M | -3,093.84%-67.87M | -1,960.56%-16.88M | 3,231.94%17.95M | -6,462.08%-43.44M | -35,812.68%-25.5M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1.74%97.29M | -2.33%92.99M | 1,463.46%1.63M | 701.94%2.48M | 1,082.35%201K | -42.48%95.63M | 18.79%95.2M | 109.32%104K | 220.70%309K | -99.98%17K |
| Net common stock issuance | -62.92%3.17M | --0 | --1.35M | ---- | ---- | -89.14%8.55M | --8.55M | --0 | ---- | ---- |
| Net preferred stock issuance | 6.89%92.62M | ---- | ---- | ---- | ---- | -0.66%86.65M | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 249.77%1.5M | --369K | 163.46%274K | 113.59%660K | 1,082.35%201K | 23.21%430K | --0 | 420.00%104K | 1,445.00%309K | -93.58%17K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1.74%97.29M | -2.33%92.99M | 1,463.46%1.63M | 701.94%2.48M | 1,082.35%201K | -42.48%95.63M | 18.79%95.2M | 109.32%104K | 220.70%309K | -99.98%17K |
| Net cash flow | ||||||||||
| Beginning cash position | -17.99%122.37M | -9.17%56.37M | -11.41%48.52M | -63.81%39.28M | -17.99%122.37M | 753.27%149.21M | -24.29%62.06M | -40.69%54.77M | 8.78%108.53M | 753.27%149.21M |
| Current changes in cash | -199.99%-80.52M | -124.08%-14.52M | 7.71%7.85M | 117.19%9.24M | -104.25%-83.09M | -120.38%-26.84M | -10.30%60.31M | 170.24%7.29M | -625.02%-53.76M | -149.44%-40.68M |
| End cash Position | -65.80%41.85M | -65.80%41.85M | -9.17%56.37M | -11.41%48.52M | -63.81%39.28M | -17.99%122.37M | -17.99%122.37M | -24.29%62.06M | -40.69%54.77M | 8.78%108.53M |
| Free cash flow | -15.91%-64.56M | 3.63%-17.7M | -43.15%-15.49M | -38.65%-14.84M | -4.57%-16.52M | -61.27%-55.7M | -42.36%-18.37M | -16.84%-10.82M | -49.49%-10.7M | -203.36%-15.8M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg